Content Type (RSS): In the News

  • Is Big Law’s Nonequity Tier a ‘Parking Lot’ or a ‘Ladder’?

    Is Big Law’s Nonequity Tier a ‘Parking Lot’ or a ‘Ladder’?

    COVERAGE

    Is Big Law’s Nonequity Tier a ‘Parking Lot’ or a ‘Ladder’?

    October 1, 2024

    Read time: 2 min

    About Us

    Ira J. Coleman

    Chairman

    Miami

    You may also like

  • Claiming Foreign Tax Credits Arising from Never-Ending Foreign Audits—An Overview

    Claiming Foreign Tax Credits Arising from Never-Ending Foreign Audits—An Overview

    COVERAGE

    Claiming Foreign Tax Credits Arising from Never-Ending Foreign Audits—An Overview

    October 1, 2024

    Read time: 2 min

    About Us

    Brian H. Jenn

    Partner

    Washington, DC, Chicago

    You may also like

  • McDermott Adds New Director of AI Innovation

    McDermott Adds New Director of AI Innovation

    PRESS RELEASE

    McDermott Adds New Director of AI Innovation

    September 30, 2024

    Read time: 4 min

    International law firm McDermott Will & Emery welcomes Christopher Cyrus as its first Director of AI Innovation. A seasoned attorney and consultant with a rich background in law and technology, Christopher will lead the Firm’s efforts in exploring, adopting and implementing cutting-edge artificial intelligence (AI) solutions.

    “We believe the business of law will continue to be disrupted and evolve through AI and this addition to our team marks a significant step forward in our commitment to innovation,” said Michael Shea, McDermott’s Chief Information Officer. “Christopher’s expertise will be instrumental in driving AI use cases and adoption within our practice groups. His unique blend of legal and technological expertise will help us source best in class AI technology and ensure we’re deploying these tools in intelligent ways to improve operational efficiency.”

    Leveraging his background as a litigator, Christopher has expertise in creatively using AI to work more efficiently on a number of attorney-facing use cases. He has consulted with professionals from AmLaw 50 firms, in-house legal departments and T-15 law school faculty on incorporating large language models and other transformer-architecture technologies into their workflows.

    In his new position, Christopher will serve as a champion and advocate for AI technologies within the Firm, highlighting success stories, potential use cases and the strategic advantages of AI adoption. He will collaborate with attorneys, IT staff and management to identify opportunities for AI to enhance legal services and operational efficiency, critically evaluating new tools and driving successful delivery of custom and third-party solutions. Christopher will also plan and execute custom AI solution deployments.

    “I look forward to helping McDermott lawyers leverage AI to deliver even more value to their clients and the Firm,” Christopher said. “As Wharton Professor Ethan Mollick has explained, generative AI is a once-in-a-generation technology that touches every industry and every aspect of life. Like Mollick, I believe GenAI’s unique and powerful functionalities can best be tapped by those who understand parts of culture more deeply than everyone else. The lawyers at McDermott are all knowledge leaders in their field and are well positioned to capitalize on this technology.”

    The appointment, and creation of the Director of AI Innovation role, is the latest milestone in McDermott’s innovation journey, which keeps the Firm ahead of the curve and propels client success. The Firm is at the forefront of technology, including experimenting with and adopting generative AI platforms. McDermott was the first AmLaw firm to implement its own ChatGPT servers, helping develop best-use cases, such as processing client data through the lens of leading large language models. In addition, the Firm made a $10M anchor investment in the LegalTech Fund in 2021, underscoring its commitment to propel client success through innovation.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve

    You may also like

  • What to Expect in the Court Case Against NYC Mayor Eric Adams

    What to Expect in the Court Case Against NYC Mayor Eric Adams

    COVERAGE

    What to Expect in the Court Case Against NYC Mayor Eric Adams

    September 27, 2024

    Read time: 2 min

    About Us

    Sagar K. Ravi

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    You may also like

  • McDermott Advises Kreissparkasse Biberach on Acquisition Financing for VTC

    McDermott Advises Kreissparkasse Biberach on Acquisition Financing for VTC

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Kreissparkasse Biberach on Acquisition Financing for VTC

    September 27, 2024

    Read time: 3 min

    Munich, September 27, 2024 – McDermott Will & Emery has advised the Kreissparkasse Biberach on the successful financing of the acquisition of Hürner Luft- und Umwelttechnik by the Munich-based private group VTC.

    Acting as Mandated Lead Arranger, Agent and Security Agent, Kreissparkasse Biberach arranged a customized syndicated loan facility with other savings banks for VTC.

    Kreissparkasse Biberach is a member of the Sparkassen-Finanzgruppe. The bank is owned by the district of Biberach. Approximately 900 employees work in about 40 branches. In 2023, Kreissparkasse Biberach had a balance sheet total of €6.49 billion.

    HLU – Hürner Luft- und Umwelttechnik is a German company with more than 180 employees that combines future-oriented air technology with sustainable environmental technology.

    Based in Munich, Germany, VTC GmbH & Co. KG is an investment holding company that focuses on both the further development of their existing group companies and the acquisition of new investments.

    The McDermott team was led by partners Ludwig Zesch and Matthias Weissinger and comprised counsel Maximilian Meyer as well as associates Franziska Sauer and Romy Lanz.

    About Us
    You may also like

  • Bringing all the Insurtechs to the Yard Since 2021

    Bringing all the Insurtechs to the Yard Since 2021

    COVERAGE

    Bringing all the Insurtechs to the Yard Since 2021

    September 26, 2024

    Read time: 2 min

    About Us

    Michael R. Halsband

    Partner

    New York – One Vanderbilt Avenue

    You may also like

  • Benefits of Specialisation for Healthcare Private Equity Funds

    Benefits of Specialisation for Healthcare Private Equity Funds

    COVERAGE

    Benefits of Specialisation for Healthcare Private Equity Funds

    September 26, 2024

    Read time: 2 min

    About Us

    Ian M. Schwartz

    Partner

    New York – One Vanderbilt Avenue

    You may also like

  • McDermott Represents H.I.G. Capital in Cross-Border Sale of its Life Sciences Portfolio Company BIOVECTRA Inc.

    McDermott Represents H.I.G. Capital in Cross-Border Sale of its Life Sciences Portfolio Company BIOVECTRA Inc.

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Represents H.I.G. Capital in Cross-Border Sale of its Life Sciences Portfolio Company BIOVECTRA Inc.

    September 25, 2024

    Read time: 3 min

    International law firm McDermott Will & Emery represented H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under management, in the sale of its portfolio company, BIOVECTRA Inc. (BIOVECTRA) to Agilent Technologies, Inc.

    BIOVECTRA is a Canada-based contract development and manufacturing organization for key ingredients used in branded drugs to treat a broad range of complex diseases. H.I.G. acquired BIOVECTRA in 2019.

    The McDermott team was led by Harris Siskind, Alex Clavero, Maria Navarro and Brad Burcroff.

    Read H.I.G.’s announcement.

    McDermott’s private equity (PE) practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated PE lawyers across 21 locations. We have ranked Pitchbook’s Top 5 Healthcare PE firm for six consecutive years and are Top 10 in PE Buyouts and other PE deals. We are also ranked as a Top 10 Global Mid-Market PE Firm by Bloomberg and #7 PE Law firm by The Deal. Learn more about our PE practice by visiting pe.mwe.com.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Alexander C. Clavero

    Partner

    Miami, New York – One Vanderbilt Avenue

    Maria B. Navarro

    Partner

    Miami

    You may also like

  • McDermott Represents Flourish Research in a Majority Investment from Genstar Capital

    McDermott Represents Flourish Research in a Majority Investment from Genstar Capital

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Represents Flourish Research in a Majority Investment from Genstar Capital

    September 24, 2024

    Read time: 3 min

    International law firm McDermott Will & Emery represented NMS Capital (NMS) and its portfolio company Flourish Research (Flourish), a leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience and infectious disease therapeutic areas among others, in a strategic majority investment from Genstar Capital (Genstar), a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrials industries.

    McDermott represented NMS in its formation of Flourish and acquisition of Clinical Trials of Texas in 2021, and has, since, worked closely with NMS and Flourish to support its growth and operations as it developed a network of 24 sites and 150 investigators conducting studies spanning all phases of clinical trial research.

    The McDermott team included Bernie Grondin, Dana Dombey, Chelsea Rogers, Morgan Pollard, Karis Jackson, Sarah Kitchell, Kyle Hafkey, Jae Lee, Paul Gadiock, Marissa Hill Daley, Deepali Doddi, Alex Ruiz, Kwabena Yeboah, Abigail Kagan, Dawn Peacock, Greg Heltzer, Ty Carson, Sarah Bro, Courtney Seams, Elena Otero, Kristi Mankowske, Jeffrey Holdvogt, Jennifer Hill, and Joshua Samis.

    Read the announcement.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Dana Dombey

    Partner

    Miami

    Chelsea Rogers

    Partner

    Miami

    Morgan A. Pollard

    Partner

    Atlanta

    Sarah Kitchell

    Partner

    Boston

    Kyle E. Hafkey

    Associate

    Boston

    Jae Hyun Lee

    Associate

    New York – One Vanderbilt Avenue

    Paul S. Gadiock

    Partner

    San Francisco

    Marissa Hill Daley

    Law Clerk

    Washington, DC

    Alejandro Ruiz

    Partner

    San Francisco

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    Gregory E. Heltzer

    Partner

    Washington, DC

    Timothy (Ty) Carson

    Counsel

    Washington, DC

    Sarah Bro

    Partner

    Orange County, Los Angeles

    Courtney Cecile Seams

    Associate

    Washington, DC

    Elena Otero

    Partner

    Miami

    Jeffrey M. Holdvogt

    Partner

    Chicago

    Jennifer D. Hill

    Associate

    Atlanta

    Joshua Samis

    Partner

    Chicago

    You may also like

  • McDermott Advises Aukera Energy on the Acquisition of a Photovoltaic Project in Germany

    McDermott Advises Aukera Energy on the Acquisition of a Photovoltaic Project in Germany

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Aukera Energy on the Acquisition of a Photovoltaic Project in Germany

    September 24, 2024

    Read time: 3 min

    Frankfurt, September 24, 2024 – McDermott Will & Emery has advised Aukera Energy on the acquisition of a photovoltaic project in Rhineland-Palatinate, Germany, by way of a share deal. The seller is a German renewable energy project developer.

    The PV project is expected to have a capacity of 46 MW for photovoltaics and 40 MW for BESS. It is expected to be ready for construction by the first quarter of 2025.

    Aukera Energy focuses on the development, construction and operation of solar, wind and battery storage projects. Headquartered in Brussels and with offices in London, Edinburgh, Berlin, Rome and Bucharest, the company is currently developing a pipeline of 15 GW.

    McDermott’s Energy & Infrastructure team regularly advises on a wide range of projects and transactions in the energy and infrastructure sectors, as well as on issues related to the energy transition. Advising on projects in the field of renewable energies (including storage and other energy transition issues) is a particular focus of the team.

    Aukera Energy was advised by McDermott partner Maximilian Uibeleisen and his team, including counsel Simon Groneberg and associates Jan Ischreyt and Constanze Götz as well as tax counsel Maximilian Meyer.

    About Us
    You may also like